A Novel Approach to Justify Dissolution Differences in an Extended Release Drug Product using Physiologically Based Biopharmaceutics Modeling and Simulation-Reference-Cited by-同舟云学术

A Novel Approach to Justify Dissolution Differences in an Extended Release Drug Product using Physiologically Based Biopharmaceutics Modeling and Simulation

Published:2022-06 Issue:6 Volume:111 Page:1820-1832
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Aishwarya R.,Murthy Aditya^ORCID,Ahmed Tausif,Chachad Siddharth

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference50 articles.

1. Establishing the bioequivalence safe space for immediate-release oral dosage forms using physiologically based biopharmaceutics modeling (PBBM): case studies;Heimbach;J Pharm Sci,2021

2. Development, validation and application of physiologically based biopharmaceutics model to justify the change in dissolution specifications for DRL ABC extended release tablets;Jaiswal;Drug Dev Ind Pharm,2021

3. A mechanistic physiologically-based biopharmaceutics modeling (PBBM) approach to assess the in vivo performance of an orally administered drug product: from IVIVC to IVIVP;Bermejo;Pharmaceutics,2020

4. PBPK models for the prediction of in vivo performance of oral dosage forms;Kostewicz;Eur J Pharm Sci,2014

5. PBPK Absorption Modeling to Support Risk Assessment and Biowaiver for Generic Oral Products,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating gender effect in the generic bioequivalence studies by physiologically based pharmacokinetic modeling – A case study of dextromethorphan modified release tablets;Biopharmaceutics & Drug Disposition;2024-05-22

2. Development of Extended-Release Formulations Containing Cyclobenzaprine Based on Physiologically Based Biopharmaceutics Modeling and Bioequivalence Safe Space;Journal of Pharmaceutical Sciences;2023-07

3. Modelling Based Approaches to Support Generic Drug Regulatory Submissions-Practical Considerations and Case Studies;The AAPS Journal;2023-06-23